High comorbidity indexes predict 30-day mortality after percutaneous endoscopic gastrostomy

Author:

Kuwai Toshio1,Kusunoki Ryusaku1,Kuwai Toshio1,Tamaru Yuzuru1,Mizumoto Takeshi1,Semba Shigeaki1,Kato Naohiro1,Sugata Shuhei1,Okuda Yasuhiro1,Teraoka Yuji1,Yamaguchi Atsushi1,Kouno Hirotaka1

Affiliation:

1. National Hospital Organization, Kure Medical Center, and Chugoku Cancer Center

Abstract

Abstract Background High postoperative mortality rates have been reported for percutaneous endoscopic gastrostomy (PEG), although guidelines recommend PEG for patients anticipated inability of oral intake for more than 4 weeks. Conversely, comorbidity indexes have not been adequately validated among patients who underwent PEG. We evaluated comorbidity indexes and clinical risk factors for 30-day mortality after PEG. Methods We retrospectively reviewed 1,395 patients who underwent PEG at our hospital from April 2008 to December 2020. We used the direct introducer procedure to perform PEG and compared preprocedural clinical factors, demographics, comorbidity indexes, (Charlson comorbidity index [CCI] and cumulative illness rating scale [CIRS]), and laboratory data of patients who survived and those who died within 30 days after PEG. Results A total of 104 (7.5%) patients died within 30 days after PEG. Multivariate logistic regression analysis revealed association of 30-day mortality with patients’ age of ≥ 80 years, total parental nutrition before PEG, CCI of ≥ 5, CIRS of ≥ 13, and serum C-reactive protein level of ≥ 2.6 mg/dl. The receiver operating characteristics analysis revealed CIRS as the best 30-day mortality predictor (area under the curve: 0.80; 95% CI: 0.75–0.85). The 30-day mortality among the highest quartile of CCI and CIRS groups were 16.9% and 20.3%, respectively. Kaplan–Meyer analysis revealed that multivariable-adjusted hazard ratios are favored lower comorbidity scores. Conclusion High comorbidity indexes were associated with 30-day mortality after PEG. Comorbidity indexes must be considered while predicting patients’ prognosis to reduce inappropriate performance of PEG.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3